OKYO Pharma | Results Presentation Deck | 25 slides · page 13 of 25
The chart shows that OK-101 (0.04%) reduces corneal permeability to levels comparable to Cyclosporine (0.1%) and significantly better than the phosphate buffer control.
Conference presentation · before_after · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 chart 1/1 image 1/1 list 1/1 source-note 1/1 title 1/1
Components 6
primary bar-vertical illustration bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.